UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 572

Sortiert nach

Depth of invasion as a predictor of nodal disease and survival in patients with oral tongue squamous cell carcinoma

Head & neck, 2019-01, Vol.41 (1), p.177-184

2019

Volltextzugriff (PDF)

Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes

Journal of clinical oncology, 2015-10, Vol.33 (29), p.3262-3268

2015

Volltextzugriff (PDF)

Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

Journal of clinical oncology, 2013-03, Vol.31 (7), p.845-852

2013

Volltextzugriff (PDF)

Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3582-3589

2008

Volltextzugriff (PDF)

Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy

Cancer, 2016-02, Vol.122 (4), p.546-558

2016

Volltextzugriff (PDF)

Multifield Optimization Intensity Modulated Proton Therapy for Head and Neck Tumors: A Translation to Practice

International journal of radiation oncology, biology, physics, 2014-07, Vol.89 (4), p.846-853

2014

Volltextzugriff (PDF)

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522

Journal of clinical oncology, 2014-09, Vol.32 (27), p.2940-2950

2014

Volltextzugriff (PDF)

Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance

Clinical cancer research, 2010-10, Vol.16 (19), p.4722-4731

2010

Volltextzugriff (PDF)

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity

Journal of clinical oncology, 2014-12, Vol.32 (34), p.3858-3867

2014

Volltextzugriff (PDF)

Intestinal-Type Adenocarcinoma in Head and Neck: Dissecting Oncogenic Gene Alterations Through Whole Transcriptome and Exome Analysis

Modern pathology, 2024-01, Vol.37 (1), p.100372-100372, Article 100372

2024

Volltextzugriff (PDF)

Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland

Virchows Archiv : an international journal of pathology, 2020-02, Vol.476 (2), p.295-305

2020

Volltextzugriff (PDF)

Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations

Clinical cancer research, 2016-02, Vol.22 (3), p.725-733

2016

Volltextzugriff (PDF)

National Cancer Database report on cancer of the head and neck: 10-Year update

Head & neck, 2009-06, Vol.31 (6), p.748-758

2009

Volltextzugriff (PDF)

Prognostic factors in mucoepidermoid carcinoma of the salivary glands

Cancer, 2012-08, Vol.118 (16), p.3928-3936

2012

Volltextzugriff (PDF)

Head and Neck Cancer : An Evolving Treatment Paradigm

Cancer, 2008-10, Vol.113 (7), p.1911-1932

2008

Volltextzugriff (PDF)

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer

Journal of clinical oncology, 2017-12, Vol.35 (36), p.4057-4065

2017

Volltextzugriff (PDF)

CpG island methylation profiling in human salivary gland adenoid cystic carcinoma

Cancer, 2011-07, Vol.117 (13), p.2898-2909

2011

Volltextzugriff (PDF)

Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation

Cancer, 2017-01, Vol.123 (1), p.62-70

2017

Volltextzugriff (PDF)

Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2017-08, Vol.98 (5), p.1002-1011

2017

Volltextzugriff (PDF)

Prognosis and risk factors for early‐stage adenoid cystic carcinoma of the major salivary glands

Cancer, 2012-06, Vol.118 (11), p.2872-2878

2012

Volltextzugriff (PDF)

MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome

PloS one, 2013-06, Vol.8 (6), p.e66778

2013

Volltextzugriff (PDF)

A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck

Clinical cancer research, 2012-03, Vol.18 (5), p.1435-1446

2012

Volltextzugriff (PDF)

Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Clinical cancer research, 2021-08, Vol.27 (16), p.4557-4565

2021

Volltextzugriff (PDF)

1 – 25 von 572

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(507)
Mit Volltextzugriff
(474)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(565)
Japanisch
(103)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Depth of invasion as a predictor of nodal disease and survival in patients with oral tongue squamous cell carcinoma

Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes

Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy

Multifield Optimization Intensity Modulated Proton Therapy for Head and Neck Tumors: A Translation to Practice

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522

Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity

Intestinal-Type Adenocarcinoma in Head and Neck: Dissecting Oncogenic Gene Alterations Through Whole Transcriptome and Exome Analysis

Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland

Validation of NRG oncology/RTOG‐0129 risk groups for HPV‐positive and HPV‐negative oropharyngeal squamous cell cancer: Implications for risk‐based therapeutic intensity trials

Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations

Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy

National Cancer Database report on cancer of the head and neck: 10-Year update

Prognostic factors in mucoepidermoid carcinoma of the salivary glands

Head and Neck Cancer : An Evolving Treatment Paradigm

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer

CpG island methylation profiling in human salivary gland adenoid cystic carcinoma

Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation

Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer

Prognosis and risk factors for early‐stage adenoid cystic carcinoma of the major salivary glands

MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome

A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck

Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Suchergebnisse filtern